EFFECT OF ANTIPSYCHOTIC WITHDRAWAL ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIA

被引:25
作者
MILLER, DD
FLAUM, M
ARNDT, S
FLEMING, F
ANDREASEN, NC
机构
[1] Mental Health Clinical Research Center, University of Iowa Hospitals and Clinics, Iowa City, IA
[2] University of Iowa Hospitals and Clinics, Department of Psychiatry Administration, Iowa City, IA, 52242-1057, Rm 2887 JPP
关键词
NEGATIVE SYMPTOMS; ANTIPSYCHOTIC WITHDRAWAL;
D O I
10.1038/npp.1994.31
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although it is generally accepted that antipsychotic treatment improves the negative symptoms of schizophrenia in the context of improvement of positive symptoms, exactly how and to what extent they effect ''primary'' negative symptoms remains controversial. Antipsychotic treatment may reduce only those negative symptoms secondary to positive or depressive symptoms, and may have minimal, if any effect, on negative symptoms that represent a primary psychopathological trait manifestation of schizophrenia. In an effort to further examine this issue, we prospectively assessed negative, positive, depressive, and extrapyramidal symptoms following the discontinuation of antipsychotic medication. Fifty-nine DSM III-R schizophrenic patients underwent a three-week drug wash as part of our neuroimaging protocols. We assessed psychopathological status and adverse effects utilizing various rating instruments (i.e., Scale for Assessment of Positive Symptoms [SAPS], Scale for Assessment of Negative Symptoms [SANS], Hamilton Rating Scale for Depression, and Simpson-Angus Extrapyramidal) at baseline and weekly during this three-week period. Negative symptoms, as measured by the SANS, worsened significantly during the three-week drug wash. Positive symptoms showed a less consistent change with symptoms of disorganization worsening and with psychotic symptoms remaining the same. The changes in negative symptoms during the drug-free period were correlated with the changes in psychosis and disorganization, but not with changes in depression or extrapyramidal side effects. We were not able to substantiate if the worsening in negative symptoms was a direct result of the worsening of positive symptoms or if they were changing simultaneously, but independent of each other.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 70 条
[1]  
Agresti A, 1990, CATEGORICAL DATA ANA
[2]  
Andreasen, 1984, SCALE ASSESSMENT POS
[3]  
ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615
[4]  
ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784
[5]  
Andreasen NC, 1987, COMPREHENSIVE ASSESS
[6]  
Andreasen NC., 1986, PSYCHIAT PSYCHOBIOL, V1, P108
[7]   CONTROLLED TRIAL OF PHENOTHIAZINE WITHDRAWAL IN CHRONIC-SCHIZOPHRENIC PATIENTS [J].
ANDREWS, P ;
HALL, JN ;
SNAITH, RP .
BRITISH JOURNAL OF PSYCHIATRY, 1976, 128 (MAY) :451-455
[8]   DIFFERENTIAL-EFFECTS OF AMPHETAMINE AND NEUROLEPTICS ON NEGATIVE VS POSITIVE SYMPTOMS IN SCHIZOPHRENIA [J].
ANGRIST, B ;
ROTROSEN, J ;
GERSHON, S .
PSYCHOPHARMACOLOGY, 1980, 72 (01) :17-19
[9]   EFFECT OF NEUROLEPTICS ON POSITIVE AND NEGATIVE SYMPTOMS AND THE DEFICIT STATE [J].
ANGST, J ;
STASSEN, HH ;
WOGGON, B .
PSYCHOPHARMACOLOGY, 1989, 99 :S41-S46
[10]  
[Anonymous], 1984, SCALE ASSESSMENT POS